HDAC inhibition does not induce estrogen receptor in human triple-negative breast cancer cell lines and patient-derived xenografts.
about
HDACs and HDAC Inhibitors in Cancer Development and Therapy.Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and PromisesBoth bulk and cancer stem cell subpopulations in triple-negative breast cancer are susceptible to Wnt, HDAC, and ERα coinhibition.Targeting triple negative breast cancer with histone deacetylase inhibitors.Impact of genistein on the gut microbiome of humanized mice and its role in breast tumor inhibition.
P2860
HDAC inhibition does not induce estrogen receptor in human triple-negative breast cancer cell lines and patient-derived xenografts.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
HDAC inhibition does not induc ...... nd patient-derived xenografts.
@en
HDAC inhibition does not induc ...... nd patient-derived xenografts.
@nl
type
label
HDAC inhibition does not induc ...... nd patient-derived xenografts.
@en
HDAC inhibition does not induc ...... nd patient-derived xenografts.
@nl
prefLabel
HDAC inhibition does not induc ...... nd patient-derived xenografts.
@en
HDAC inhibition does not induc ...... nd patient-derived xenografts.
@nl
P2093
P2860
P1476
HDAC inhibition does not induc ...... and patient-derived xenografts
@en
P2093
André Nicolas
Brian Paul Lockhart
Didier Decaudin
Fatima Moutahir
Franck Assayag
Gaëlle Rolland
Hugues de Thé
Jacqueline Lehmann-Che
Laurence Kraus-Berthie
Mathieu Dalvai
P2860
P2888
P356
10.1007/S10549-014-3233-Y
P407
P577
2014-12-12T00:00:00Z